3654 results for «415»

Filter By

3654 results

Coronary Pot Pourri 1

10 Dec 2025 – From GulfPCR-GIM 2025

This session presents a diverse array of challenging coronary cases, highlighting complex diagnostic and therapeutic dilemmas. It offers practical insights into decision-making for scenarios such as difficult catheterizations, myocardial bridging, and unexpected procedural challenges.

Coronary Pot Pourri 1

The most impactful trials of 2025

10 Dec 2025 – From GulfPCR-GIM 2025

Review the most impactful cardiovascular intervention trials anticipated in 2025, analyzing their methodology and clinical applicability. This session facilitates understanding how emerging evidence can be integrated into daily interventional cardiology practice.

The most impactful trials of 2025

Cracking calcium in modern PCI

10 Dec 2025 – From GulfPCR-GIM 2025

Calcified coronary lesions are a major challenge in PCI. This PCRGulf-GIM 2025 session showcases a complex case with intravascular imaging, highlighting how IVUS 123 guides each step.

From planning the procedure and understanding calcium distribution, to lesion preparation with modern modification tools, and post-PCI assessment to confirm...

Cracking calcium in modern PCI

Challenging TAVI cases - Part 1

10 Dec 2025 – From GulfPCR-GIM 2025

Addressing complex TAVI cases, this session focuses on procedural challenges and advanced strategies to optimize safety and outcomes. Topics include high-risk valvuloplasty, management with prosthetic valves, and considerations in patients with valve thrombus.

Challenging TAVI cases - Part 1

GulfPCR-GIM 2025 Opening Ceremony

10 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.

GulfPCR-GIM 2025 Opening Ceremony

GulfPCR-GIM 2025 Closing Ceremony

11 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.

GulfPCR-GIM 2025 Closing Ceremony

Seeing is believing: OCT-guided calcium modification in complex PCI

10 Dec 2025 – From GulfPCR-GIM 2025

Explore the management of heavily calcified LAD lesions in this PCRGulf-GIM 2025 session. Discover how OCT imaging guides lesion assessment, differentiates superficial from deep calcium, and informs the need for plaque modification. Learn when and how to use orbital atherectomy or intravascular lithotripsy, and follow the...

Seeing is believing: OCT-guided calcium modification in complex PCI

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

10 Dec 2025 – From GulfPCR-GIM 2025

This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.

The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

Complex bifurcation interventions

10 Dec 2025 – From GulfPCR-GIM 2025

This session examines complex bifurcation interventions, addressing challenging cases such as isolated Medina 0,0,1 left main bifurcation and imaging-guided trifurcation angioplasty in acute coronary syndromes. It emphasizes strategic approaches and device selection to overcome anatomical complexities, manage complications, and achieve successful outcomes in bifurcation PCI.

Complex bifurcation interventions

Artificially synthesized optical coherence tomography images based on intravascular ultrasound-virtual histology examination of diseased coronary artery

05 May 2021

Intravascular imaging is a cornerstone of invasive management of coronary disease, requiring specialized training to interpret either IVUS or OCT. AI can facilitate interpretation by non-specialists in real time.

AI-generated synthetic OCT

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan
Ali Nazmi Calik

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?